AdaptHealth Corp. (AHCO) Guidance & Earnings Results

On 2026-08-04 AdaptHealth Corp. lowered guidance: "FY26 revenue $2.85-2.89B (prior not stated); FY26 adjusted EBITDA $490-520M from $680-730M; FY26 free cash flow…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

AHCOAdaptHealth Corp.Follow AHCO — free

Medical Devices · Healthcare

—

Price chart with a free account

Market cap: 820.8M
P/E TTM: —
Dividend yield: —
52-week: —
Next earnings: 3 Nov, in 10 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
4 Aug 26	Lowered	FY26 revenue $2.85-2.89B (prior not stated); FY26 adjusted EBITDA $490-520M from $680-730M; FY26 free cash flow $80-120M · full year
24 Feb 26	Raised	FY2026 guidance provided · full year
4 Nov 25	Reaffirmed	FY revenue $3.18B-$3.26B; adjusted EBITDA $642M-$682M; FCF $170M-$190M. · full year
5 Aug 25	Lowered	FY25 revenue narrowed to $3.18-3.26B from $3.15-3.29B; FY25 Adjusted EBITDA lowered to $642-682M from $662-702M; FY25 free cash flow unchanged $170-190M · full year

AdaptHealth Corp. — questions

What guidance did AdaptHealth Corp. give?: On 2026-08-04: "FY26 revenue $2.85-2.89B (prior not stated); FY26 adjusted EBITDA $490-520M from $680-730M; FY26 free cash flow $80-120M"
When does AdaptHealth Corp. report earnings?: AdaptHealth Corp.'s next earnings report is expected on 2026-11-03.

Every figure on this page comes from AdaptHealth Corp.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.